Weekly administration of temsirolimus for heavily pretreated patients with clear cell carcinoma of the ovary: a report of six cases

Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma

Gary R. Hudes, Michael A. Carducci, Piotr Tomczak et al. · New England Journal of Medicine · 2007 · 3.6K citations

Medicine, Oncology, Chemotherapy +10

Regulation of Hypoxia-Inducible Factor 1α Expression and Function by the Mammalian Target of Rapamycin

Christine C. Hudson, Mei Liu, Gary G. Chiang et al. · Molecular and Cellular Biology · 2002 · 1.2K citations · Full text

Medicine, Oncology, Pharmacology +15

Randomized Phase II Study of Multiple Dose Levels of CCI-779, a Novel Mammalian Target of Rapamycin Kinase Inhibitor, in Patients With Advanced Refractory Renal Cell Carcinoma

Michael B. Atkins, Manuel Hidalgo, Walter M. Stadler et al. · Journal of Clinical Oncology · 2004 · 943 citations · Full text

Pharmacy, Oncology, Pharmacology +16

Clinical characteristics of clear cell carcinoma of the ovary

Toru Sugiyama, Toshiharu Kamura, Junzo Kigawa et al. · Cancer · 2000 · 804 citations

Medicine, Oncology, Pathology +14

Safety and Pharmacokinetics of Escalated Doses of Weekly Intravenous Infusion of CCI-779, a Novel mTOR Inhibitor, in Patients With Cancer

Éric Raymond, Jérôme Alexandre, Sandrine Faivre et al. · Journal of Clinical Oncology · 2004 · 500 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16